These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31528833)

  • 21. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F;
    J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of the post-captopril test in primary aldosteronism.
    Castro OL; Yu X; Kem DC
    Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population.
    Zhu KY; Zhang Y; Zhang WJ; Li HY; Feng WH; Zhu DL; Li P
    BMC Endocr Disord; 2019 Jun; 19(1):65. PubMed ID: 31234846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case detection in primary aldosteronism: high-diagnostic value of the aldosterone-to-renin ratio when performed under standardized conditions.
    Vorselaars WMCM; Valk GD; Vriens MR; Westerink J; Spiering W
    J Hypertens; 2018 Jul; 36(7):1585-1591. PubMed ID: 29528872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of Screening Primary Aldosteronism by Aldosterone-to-Direct Renin Concentration Ratio Derived from Chemiluminescent Immunoassay Measurement: Diagnostic Accuracy and Cutoff Value.
    Li T; Ma Y; Zhang Y; Liu Y; Fu T; Zhang R; Kang K; Yang Y; Wang L; Jiang Y; Lu Y
    Int J Hypertens; 2019; 2019():2195796. PubMed ID: 31354984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.
    Kuo CC; Balakrishnan P; Hsein YC; Wu VC; Chueh SC; Chen YM; Wu KD; Wang MJ;
    J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):587-98. PubMed ID: 25031295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism.
    Kaneko H; Umakoshi H; Ishihara Y; Sugawa T; Nanba K; Tsuiki M; Kusakabe T; Satoh-Asahara N; Yasoda A; Tagami T
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):737-742. PubMed ID: 31618467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mild primary aldosteronism (PA) followed by overt PA are possibly the most common forms of low renin hypertension: a single-center retrospective study.
    Luo Q; Li N; Wang M; Yao X; Heizhati M; Zhang D; Zhou K; Wang G; Hu J; Zhu B
    J Hum Hypertens; 2020 Sep; 34(9):633-640. PubMed ID: 31792441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.
    Markou A; Pappa T; Kaltsas G; Gouli A; Mitsakis K; Tsounas P; Prevoli A; Tsiavos V; Papanastasiou L; Zografos G; Chrousos GP; Piaditis GP
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1409-16. PubMed ID: 23471976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Validation of Criteria for Sparing Confirmatory Tests in Diagnosing Primary Aldosteronism.
    Wang K; Hu J; Yang J; Song Y; Fuller PJ; Hashimura H; He W; Feng Z; Cheng Q; Du Z; Wang Z; Ma L; Yang S; Li Q
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32449927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary aldosteronism: Aldosterone/renin ratio cut-off points.
    Eugenio Russmann ML; Delfino L; Fierro F; Santoro S; Peréz M; Caruso G; Glikman P; Gauna A; Lupi S
    Endocrinol Diabetes Nutr (Engl Ed); 2019; 66(6):361-367. PubMed ID: 30737120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension.
    Hu Y; Zhang J; Liu W; Su X
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32163576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence and a long delay in the diagnosis of primary aldosteronism among patients with young-onset hypertension.
    Alam S; Kandasamy D; Goyal A; Vishnubhatla S; Singh S; Karthikeyan G; Khadgawat R
    Clin Endocrinol (Oxf); 2021 Jun; 94(6):895-903. PubMed ID: 33393127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Association between eGFR and the Aldosterone-to-Renin Ratio and Its Effect on Screening for Primary Aldosteronism.
    Xu J; Yang Y; Ling Y; Lu Z; Gao X; Li X; Li X
    Int J Endocrinol; 2020; 2020():2639813. PubMed ID: 32089681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline Plasma Aldosterone Level and Renin Activity Allowing Omission of Confirmatory Testing in Primary Aldosteronism.
    Kawashima J; Araki E; Naruse M; Kurihara I; Takahashi K; Tamura K; Kobayashi H; Okamura S; Miyauchi S; Yamamoto K; Izawa S; Suzuki T; Tanabe A
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32157288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Confirmatory Tests for the Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study.
    Song Y; Yang S; He W; Hu J; Cheng Q; Wang Y; Luo T; Ma L; Zhen Q; Zhang S; Mei M; Wang Z; Qing H; Bruemmer D; Peng B; Li Q;
    Hypertension; 2018 Jan; 71(1):118-124. PubMed ID: 29158354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma aldosterone concentration is associated with white matter lesions in patients with primary aldosteronism.
    Yuan Y; Li N; Liu Y; Wang M; Heizhati M; Zhu Q; Yao X; Luo Q
    Endocrine; 2022 Mar; 75(3):889-898. PubMed ID: 34780033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Aldosterone and Potassium Levels in Sparing Confirmatory Tests in Primary Aldosteronism.
    Umakoshi H; Sakamoto R; Matsuda Y; Yokomoto-Umakoshi M; Nagata H; Fukumoto T; Ogata M; Ogawa Y
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31665338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldosterone Reduction Rate After Saline Infusion Test May Be a Novel Prediction in Patients With Primary Aldosteronism.
    Nagano H; Kono T; Saiga A; Kubota Y; Fujimoto M; Felizola SJA; Ishiwata K; Tamura A; Higuchi S; Sakuma I; Hashimoto N; Suzuki S; Koide H; Takeshita N; Sakamoto S; Ban T; Yokote K; Nakamura Y; Ichikawa T; Uno T; Tanaka T
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31628466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computed tomography combined with confirmatory tests for the diagnosis of aldosterone-producing adenoma.
    Chen S; Liu H; Luo P; Yu Y
    Endocr J; 2021 Mar; 68(3):299-306. PubMed ID: 33100281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.